10222 BARNES CANYON ROAD, BLDG. #2, SAN DIEGO, CA
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Chief Development Officer Resignation - Jeff Knight Steps Down
Jeff Knight Resigns as Chief Development and Operating Officer
Crinetics Pharmaceuticals Dismisses BDO as Independent Auditor
Financial Results, Press Release
Executive Title Change - Jeff Knight Promoted to Chief Development Officer
Beyond Building Innovation the Premier to Impact: Endocrinology Business Conference
Q1
FY 2024
Q3
Q2
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership